Acyclovir — Trusted, Clinically Proven Antiviral for HSV & Shingles

Acyclovir is a well‑established antiviral therapy used worldwide for managing herpes simplex and varicella‑zoster infections. Its strong evidence base, long‑term safety profile, and broad clinical adoption make it a key treatment option in antiviral care.

Explore Acyclovir Options →

Table of Contents

►

Overview

Acyclovir 400mg

Acyclovir is a widely used antiviral medication designed to inhibit the replication of herpesviruses, including HSV‑1, HSV‑2, and varicella‑zoster virus. Its long‑established clinical profile, predictable pharmacokinetics, and strong safety record make it a foundational therapy in the management of herpes infections. Acyclovir is available in oral, topical, and intravenous formulations, allowing flexible use across mild, moderate, and severe clinical presentations.

Due to its targeted mechanism of action, Acyclovir remains one of the most trusted antiviral agents worldwide, frequently recommended for both episodic treatment and long‑term suppressive therapy. Its affordability and broad availability further reinforce its role as a first‑line antiviral option.

Medical Uses

Acyclovir is widely used in clinical practice for managing infections caused by herpesviruses. It is considered a foundational antiviral therapy due to its predictable pharmacological behavior, extensive safety data, and strong evidence base. Acyclovir is commonly utilized for episodic treatment, outbreak suppression, and reducing viral shedding in recurrent infections.

Dosage & Administration

Acyclovir dosing varies depending on the infection type, severity, and clinical goals. Oral formulations are commonly used for mild to moderate infections, while intravenous administration may be considered in hospital settings for severe or disseminated disease. The table below outlines typical dosing patterns referenced in clinical guidelines.

Indication Typical Adult Dose Frequency Duration
Cold sores (HSV‑1) 400 mg 3× daily 5 days
Genital herpes — initial episode 400 mg 3× daily 7–10 days
Genital herpes — recurrent 400 mg 3× daily 5 days
Suppressive therapy 400 mg 2× daily Long‑term
Shingles (herpes zoster) 800 mg 5× daily 7–10 days

How Acyclovir Works

Acyclovir is a nucleoside analogue that selectively targets viral DNA synthesis. After entering infected cells, it undergoes phosphorylation by viral thymidine kinase, enabling it to integrate into viral DNA chains. This incorporation disrupts replication and prevents the virus from producing new infectious particles. Because activation depends on viral enzymes, Acyclovir demonstrates high selectivity and a favorable safety profile.

How to Take Acyclovir

Acyclovir is typically taken at evenly spaced intervals to maintain consistent antiviral activity. Oral tablets may be taken with or without food, depending on individual comfort. Adequate hydration is often encouraged during therapy to support renal clearance. Treatment timing is especially important for herpes outbreaks, as early initiation is associated with better clinical outcomes.

Side Effects

Acyclovir is generally well tolerated, with most reported effects being mild and transient. Side effects may vary depending on dose, duration, and formulation. The following effects have been documented in clinical literature:

Contraindications

Acyclovir may not be appropriate in certain clinical situations. Contraindications described in medical references include:

Drug Interactions

Acyclovir may interact with medications that influence renal function or compete for renal tubular secretion. Interactions noted in pharmacological references include:

Warnings & Precautions

Clinical guidelines highlight several considerations when using Acyclovir. Adequate hydration is often emphasized to support renal elimination. Individuals with pre‑existing kidney conditions may require additional monitoring. Early initiation of therapy is frequently associated with improved outcomes in herpes infections. As with any antiviral, treatment decisions should be guided by qualified healthcare professionals.

Acyclovir vs Other Antivirals

Several antiviral agents are used for herpesvirus infections. Acyclovir remains a widely trusted option, while newer agents may offer alternative dosing schedules or pharmacokinetic advantages. The comparison tiles below highlight key distinctions relevant to clinical decision‑making and patient convenience.

Acyclovir

Proven antiviral with decades of clinical use. Cost‑effective, widely available, and suitable for episodic and suppressive therapy.

  • Multiple daily doses
  • Strong safety profile
  • Broad clinical experience

Valacyclovir

A prodrug of Acyclovir with improved bioavailability. Often preferred for its simplified dosing schedule and strong clinical outcomes.

  • Less frequent dosing
  • Higher absorption
  • Comparable efficacy

Famciclovir

An alternative antiviral option with convenient dosing. Often selected based on availability, patient preference, or cost considerations.

  • Convenient dosing
  • Effective for HSV & VZV
  • Alternative to Acyclovir

Storage

Acyclovir should be stored at controlled room temperature in a dry environment away from direct heat and moisture. Tablets and capsules are typically kept in their original packaging to protect them from humidity. Topical formulations should be tightly closed after each use. As with all medications, storage recommendations may vary by manufacturer.

Secure Access to Trusted Acyclovir Options Today

Fast Access Trusted Antiviral Sources Clinically Established Options Secure Information Access Multiple Strengths Available

Review available Acyclovir formulations and compare indicative pricing to better understand antiviral options commonly used in clinical practice. Consistent and timely antiviral management plays a key role in reducing outbreak intensity and supporting long‑term control strategies.

View Acyclovir Packs →

FAQ Navigation

General Questions Usage & Dosing Mechanism & Onset Side Effects Interactions Conditions Treated

General Questions

Acyclovir is commonly used for managing infections caused by herpes simplex viruses (HSV‑1 and HSV‑2) and varicella‑zoster virus. It supports outbreak control and reduces symptom duration.

No. Acyclovir is an antiviral medication, not an antibiotic. It targets viral replication rather than bacteria.

Acyclovir does not eliminate herpes viruses from the body, but it helps reduce outbreak severity, shorten healing time, and support long‑term suppression strategies.

Yes. Acyclovir is available as oral tablets, topical creams, and intravenous formulations used in hospital settings.

Acyclovir has been widely used for several decades and remains a foundational antiviral therapy due to its strong safety and efficacy profile.

Long‑term suppressive therapy is sometimes used in clinical practice for recurrent herpes infections. Decisions about long‑term use should be guided by healthcare professionals.

Usage & Dosing

Early initiation is often associated with better outcomes, as antiviral activity is most effective when started at the onset of symptoms.

Acyclovir tablets may be taken with or without food. Some individuals prefer taking it with meals for comfort.

Hydration is often emphasized in clinical guidance because it supports renal clearance of the medication.

Suppressive therapy is sometimes used for individuals with frequent recurrences. Treatment strategies vary and should be guided by healthcare professionals.

Yes. Acyclovir is commonly used for both oral and genital herpes infections caused by HSV‑1 and HSV‑2.

Treatment duration varies depending on the infection type and clinical goals. Courses may differ between episodic and suppressive therapy.

Mechanism & Onset

Acyclovir interferes with viral DNA synthesis by integrating into viral DNA chains after activation by viral thymidine kinase. This disrupts replication and limits the virus’s ability to multiply.

Antiviral activity begins as the medication reaches therapeutic levels, but symptom improvement typically becomes noticeable over several days depending on outbreak timing.

Early initiation helps limit viral replication during the most active phase of an outbreak, which may reduce symptom severity and shorten recovery time.

Acyclovir does not eliminate the virus, but suppressive therapy may help reduce outbreak frequency and viral shedding in recurrent infections.

Acyclovir has a relatively short half‑life, which is why multiple daily doses are commonly used in clinical practice to maintain antiviral activity.

Yes. Acyclovir is used for initial episodes, recurrent outbreaks, and long‑term suppression, depending on clinical goals and individual circumstances.

Side Effects

Commonly reported effects include mild headache, fatigue, and gastrointestinal discomfort. These effects are typically temporary.

Topical formulations may occasionally cause mild skin irritation or dryness at the application site.

Serious effects are uncommon but may occur in specific clinical situations, such as dehydration or pre‑existing renal conditions.

Renal considerations are noted in clinical references, especially at higher doses or in individuals with reduced kidney function. Hydration is often emphasized.

Mild dizziness or fatigue has been reported in some cases, though these effects are typically short‑lived.

Hypersensitivity reactions are rare but documented. Any unexpected symptoms should be evaluated by qualified healthcare professionals.

Interactions

Interactions may occur when combining antivirals with overlapping metabolic pathways. Clinical references recommend evaluating combined use based on therapeutic goals and individual factors.

Medications that influence renal function or compete for renal tubular secretion may affect Acyclovir clearance. Hydration and monitoring are often emphasized in clinical guidance.

Common over‑the‑counter pain relievers are not typically associated with direct interactions, but individual circumstances may vary and should be evaluated by healthcare professionals.

Alcohol is not known to directly interact with Acyclovir, but moderation is generally advised in clinical contexts involving antiviral therapy.

Most supplements do not significantly affect Acyclovir absorption, though individual formulations may vary. Clinical references recommend reviewing supplement use when starting antiviral therapy.

Interactions may depend on the specific immunosuppressant and clinical context. Monitoring is often recommended in immunocompromised individuals receiving antiviral therapy.

Conditions Treated

Yes. Acyclovir is commonly used for managing oral herpes (HSV‑1), helping reduce outbreak duration and symptom intensity.

Acyclovir is widely used for initial and recurrent genital herpes episodes and may also be used for suppressive therapy in recurrent cases.

Yes. Acyclovir is commonly used for shingles (herpes zoster) to help reduce symptom severity and support recovery.

Acyclovir may be used in certain clinical contexts for varicella infections, particularly in individuals at increased risk of complications.

Suppressive therapy with Acyclovir may help reduce viral shedding in recurrent herpes infections, which can support long‑term management strategies.

In certain clinical situations, Acyclovir may be used as part of preventive strategies, especially in individuals with increased susceptibility to herpesvirus complications.